Works matching IS 10600280 AND DT 2023 AND VI 57 AND IP 4


Results: 16
    1

    Efficacy and Safety of Erenumab, Galcanezumab, and Fremanezumab in the Treatment of Drug-Resistant Chronic Migraine: Experience in Real Clinical Practice.

    Published in:
    Annals of Pharmacotherapy, 2023, v. 57, n. 4, p. 416, doi. 10.1177/10600280221118402
    By:
    • Cantarelli, Lorenzo;
    • Pestana Grafiña, Diana;
    • Gonzalez Perez, Amanda;
    • García Gil, Sara;
    • Gutiérrez Nicolás, Fernando;
    • Ramos Santana, Emma;
    • Navarro Dávila, Marco Antonio;
    • Otazo Pérez, Sheila María;
    • Calzado Gómez, Gloria;
    • Perez Reyes, Sergio;
    • Nazco Casariego, Gloria Julia
    Publication type:
    Article
    2

    Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney Injury.

    Published in:
    Annals of Pharmacotherapy, 2023, v. 57, n. 4, p. 408, doi. 10.1177/10600280221117993
    By:
    • Williams, Victoria L.;
    • Smithburger, Pamela L.;
    • Imhoff, Allison N.;
    • Groetzinger, Lara M.;
    • Culley, Colleen M.;
    • Burke, Clayton X.;
    • Murugan, Raghavan;
    • Lamberty, Phillip E.;
    • Mahmud, Mujtaba;
    • Benedict, Neal J.;
    • Kellum, John A.;
    • Kane-Gill, Sandra L.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16